The global Infertility Devices Market is estimated to be valued at US$ 10,129.9 Mn or Bn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Infertility devices are medical devices that aid both males and females experiencing infertility problems. They provide solutions and techniques to diagnose and treat infertility issues, allowing individuals to conceive. These devices include media and consumables, instruments, and equipment and systems.

Market key trends:
One of the key trends in the infertility devices market is the rise in the use of advanced devices and techniques for infertility treatments. Manufacturers are focusing on developing innovative products with enhanced features and functionalities. For instance, in 2020, Vitrolife launched EmbryoScope+, an advanced time-lapse incubation system for embryo monitoring and selection in IVF labs. It automates manual tasks and eliminates human errors, thereby improving outcomes. Its automated algorithms and descriptive morphology enable consistent and standardized embryo assessments. Such advanced devices are driving the growth of the infertility devices market.

SWOT Analysis
Strength: Advanced devices with high success rates of ART procedures; Growing awareness about infertility treatment options
Weakness: High cost of infertility treatment preventing access to lower income groups; Strict regulatory approvals for new devices
Opportunity: Emerging markets with growing medical tourism industries; Rising male infertility rates presenting new customer segments
Threats: Social stigma associated with infertility in certain regions; threat from low-cost generics post patent expiration of major brands

Key Takeaways
Global Infertility Devices Market Demand was valued at US$ 10,129.9 Mn in 2023 and is expected to reach over US$ 19,167 Mn by 2030, expanding at a CAGR of 8.7% during the forecast period. Growing social acceptance of ART and rising male infertility prevalence rates are expected to drive the growth.
Regional analysis: Asia Pacific region dominates the market and is projected to witness the fastest CAGR over the forecast period. This is attributable to factors such as growing medical tourism industry, favorable government policies supporting ART treatment in countries such as India.
Key players: Key players operating in the infertility devices market include Carl Zeiss Meditec AG, Thermo Fisher Scientific Inc., Vitrolife AB, The Baker Company, Inc., The Cooper Companies, Inc., Fujifilm Irvine Scientific, IVFTECH APS, Kitazato Corporation, MedGyn Products, Inc., Rocket Medical plc, SOMATEX Medical Technologies GmbH, Cook Group Incorporated, Esco Micro Pte Ltd, Hamilton Thorne, Ltd 

Read More https://makuv.com/technological-advancements-in-infertility-treatment-to-fuel-growth-of-the-infertility-devices-market/